Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.16	60.65	75	68.43	34.2	62.42
Short-Term Investments	33.92	65.04	21.53	117.16	270.99	367.31
Cash & Short-Term Investments	83.08	125.69	96.53	185.59	305.19	429.73
Cash Growth	-57.03%	30.21%	-47.99%	-39.19%	-28.98%	158.82%
Receivables	-	-	-	-	5.71	-
Prepaid Expenses	6.39	5.61	6.25	5.01	6.25	4.71
Total Current Assets	89.47	131.3	102.77	190.6	317.15	434.44
Property, Plant & Equipment	44.72	45.22	49.79	113.86	119.06	47.1
Other Long-Term Assets	3.47	3.32	3.21	3.92	3.52	1.03
Total Assets	137.65	179.84	155.77	308.37	439.73	482.57
Accounts Payable	1.82	1.61	1.92	2.24	1.39	2.81
Accrued Expenses	15.1	14.5	11.76	16.1	14.71	12.26
Current Portion of Leases	7.23	5.67	5.48	13.24	1.89	4.47
Current Income Taxes Payable	-	0.12	0.1	0.25	1.32	0.04
Other Current Liabilities	0.95	1	0.73	0.42	2.02	1.29
Total Current Liabilities	25.09	22.9	19.98	32.25	21.32	20.87
Long-Term Leases	85.95	86.04	68.57	93.56	101.11	26.24
Other Long-Term Liabilities	0.19	0.19	-	1.05	1.11	1.11
Total Liabilities	111.23	109.13	88.55	126.85	123.54	48.22
Common Stock	0	0	0	0.01	0.01	0.01
Additional Paid-In Capital	1,141	1,138	1,004	985.65	964.97	937.13
Retained Earnings	-1,114	-1,067	-936.02	-802.61	-648.08	-502.54
Comprehensive Income & Other	-0.46	-0.41	-0.47	-1.53	-0.71	-0.26
Shareholders' Equity	26.42	70.71	67.22	181.52	316.19	434.35
Total Liabilities & Equity	137.65	179.84	155.77	308.37	439.73	482.57
Total Debt	93.18	91.71	74.04	106.8	102.99	30.71
Net Cash (Debt)	-10.1	33.99	22.49	78.79	202.19	399.02
Net Cash Growth	-	51.15%	-71.46%	-61.03%	-49.33%	198.47%
Net Cash Per Share	-0.48	1.72	2.23	7.94	20.62	46.86
Filing Date Shares Outstanding	20.89	20.89	20.75	10.06	9.88	9.78
Total Common Shares Outstanding	20.89	20.85	10.14	10.01	9.84	9.75
Working Capital	64.38	108.4	82.79	158.35	295.83	413.57
Book Value Per Share	1.26	3.39	6.63	18.13	32.14	44.53
Tangible Book Value	26.42	70.71	67.22	181.52	316.19	434.35
Tangible Book Value Per Share	1.26	3.39	6.63	18.13	32.14	44.53
Machinery	16.08	15.86	15.51	16.58	15.14	11.21
Construction In Progress	0.01	0.01	0.18	1.01	4.4	1.95
Leasehold Improvements	13.78	13.78	13.59	34.34	26.7	24.63

Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q